These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25492071)

  • 1. Commentary: Craving diagnostic validity in DSM-5 Substance Use Disorders.
    Beckson M; Tucker D
    J Am Acad Psychiatry Law; 2014; 42(4):453-8. PubMed ID: 25492071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSM-5 and substance use disorders: clinicolegal implications.
    Norko MA; Fitch WL
    J Am Acad Psychiatry Law; 2014; 42(4):443-52. PubMed ID: 25492070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescents and substance-related disorders: research agenda to guide decisions on Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-V).
    Crowley TJ
    Addiction; 2006 Sep; 101 Suppl 1():115-24. PubMed ID: 16930168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substance use disorders: Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) and International Classification of Diseases, tenth edition (ICD-10).
    Hasin D; Hatzenbuehler ML; Keyes K; Ogburn E
    Addiction; 2006 Sep; 101 Suppl 1():59-75. PubMed ID: 16930162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truth (validity) and use despite consequences: the DSM-5 substance use disorder unidimensional syndrome.
    Hasin D
    Addiction; 2014 Nov; 109(11):1781-2. PubMed ID: 25297956
    [No Abstract]   [Full Text] [Related]  

  • 6. Greater Prevalence of Proposed ICD-11 Alcohol and Cannabis Dependence Compared to ICD-10, DSM-IV, and DSM-5 in Treated Adolescents.
    Chung T; Cornelius J; Clark D; Martin C
    Alcohol Clin Exp Res; 2017 Sep; 41(9):1584-1592. PubMed ID: 28667763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How should we revise diagnostic criteria for substance use disorders in the DSM-V?
    Martin CS; Chung T; Langenbucher JW
    J Abnorm Psychol; 2008 Aug; 117(3):561-75. PubMed ID: 18729609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agreement between DSM-5 and DSM-IV measures of substance use disorders in a sample of adult substance users.
    Livne O; Shmulewitz D; Stohl M; Mannes Z; Aharonovich E; Hasin D
    Drug Alcohol Depend; 2021 Oct; 227():108958. PubMed ID: 34450471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Test-retest reliability of DSM-5 substance disorder measures as assessed with the PRISM-5, a clinician-administered diagnostic interview.
    Hasin D; Shmulewitz D; Stohl M; Greenstein E; Roncone S; Aharonovich E; Wall M
    Drug Alcohol Depend; 2020 Nov; 216():108294. PubMed ID: 33007702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revising Substance-Related Disorders in the DSM-5: A History.
    Zachar P; First MB; Kendler KS
    J Stud Alcohol Drugs; 2022 Jan; 83(1):99-105. PubMed ID: 35040765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DSM-5 and Substance Use Disorders.
    Samuel RZ
    J Am Acad Psychiatry Law; 2015 Jun; 43(2):262-3. PubMed ID: 26071516
    [No Abstract]   [Full Text] [Related]  

  • 12. Dimensionality of hallucinogen and inhalant/solvent abuse and dependence criteria: implications for the Diagnostic and Statistical Manual of Mental Disorders-Fifth Edition.
    Kerridge BT; Saha TD; Smith S; Chou PS; Pickering RP; Huang B; Ruan JW; Pulay AJ
    Addict Behav; 2011 Sep; 36(9):912-8. PubMed ID: 21621334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are clinical impressions of adolescent substance use accurate?
    Wilson CR; Sherritt L; Gates E; Knight JR
    Pediatrics; 2004 Nov; 114(5):e536-40. PubMed ID: 15520086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Addictive behaviours from DSM-IV to DSM-5].
    van den Brink W
    Tijdschr Psychiatr; 2014; 56(3):206-10. PubMed ID: 24643833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Item Response Theory analyses of DSM-5 substance use disorder criteria in French outpatient addiction clinic participants. How much is craving special?
    Kervran C; Shmulewitz D; Serre F; Stohl M; Denis C; Hasin D; Auriacombe M
    Drug Alcohol Depend; 2020 Jul; 212():108036. PubMed ID: 32464467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inter-observer reliability of DSM-5 substance use disorders.
    Denis CM; Gelernter J; Hart AB; Kranzler HR
    Drug Alcohol Depend; 2015 Aug; 153():229-35. PubMed ID: 26048641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Substance-related and addictive disorders in the DSM-5].
    Thomasius R; Sack PM; Strittmatter E; Kaess M
    Z Kinder Jugendpsychiatr Psychother; 2014 Mar; 42(2):115-20. PubMed ID: 24571817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-5 (AUDADIS-5): procedural validity of substance use disorders modules through clinical re-appraisal in a general population sample.
    Hasin DS; Greenstein E; Aivadyan C; Stohl M; Aharonovich E; Saha T; Goldstein R; Nunes EV; Jung J; Zhang H; Grant BF
    Drug Alcohol Depend; 2015 Mar; 148():40-6. PubMed ID: 25604321
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction to DSM-5 criteria linked papers in drug and alcohol dependence.
    Hasin DS
    Drug Alcohol Depend; 2012 Apr; 122(1-2):20-1. PubMed ID: 22137644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The CRAFFT cut-points and DSM-5 criteria for alcohol and other drugs: a reevaluation and reexamination.
    Mitchell SG; Kelly SM; Gryczynski J; Myers CP; O'Grady KE; Kirk AS; Schwartz RP
    Subst Abus; 2014; 35(4):376-80. PubMed ID: 25036144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.